RSS

Pfizer

CytoReason has entered into a collaboration agreement with Pfizer over its machine learning model for drug discovery. Read more

News

GSK has announced it will merge its consumer healthcare business with Pfizer, in a major shake-up of the company. Read more

News

Partner and patent attorney at intellectual property firm, Withers & Rogers, Dr Nicholas Jones, discusses why drug companies should continue to pursue new medical patents in the future, despite recent examples of legal disputes. Read more

Opinion

Amid a continuing UK shortage, users of EpiPens have been told that they can continue to use the devices four months after their expiration date. Read more

News

Preclinical stage drug discovery company, CYTOO, and biopharmaceutical company, Pfizer, have announced a research collaboration with the aim of developing a target discovery platform for Duchenne Muscular Dystrophy (DMD). Read more

News

Biotechnology company, BioNTech, has entered into a multi-year research and development (R&D) collaboration with Pfizer for the development of mRNA-based vaccines for the prevention of influenza (flu). Read more

News

A brief round up of some of the latest developments in the industry, including a review into medical marijuana and a potential win for Trump in drug pricing… Read more

Opinion

Pfizer — a US based manufacturing and supply company — has announced its $465 million investment to build an advanced sterile injectable pharmaceutical production facility in Portage, Michigan. Read more

News

Pfizer and Spark Therapeutics have announced that the Phase III programme for the investigational haemophilia B gene therapy is to be initiated by Pfizer. Read more

News

UK-headquartered health tech company, Medopad, has been announced as the winner of the Pfizer Healthcare Hub Competition. Read more

News

Manager for the Pfizer Healthcare Hub: London, Dr Hamish Graham, talks to reporter Reece Armstrong about how the Hub is helping healthtech start-ups across the UK and why digital innovation is vital to the NHS. Read more

News

Researchers from the University of Oxford in collaboration with an intellectual property law firm have revealed that the NHS may be able to recoup over half a billion pounds from Pfizer if its Supreme Court patent appeal is unsuccessful Read more

News

A drug that was believed to be a promising new therapeutic option for suffers of Alzheimer’s (idalopirdine) — from the Danish pharma company, Lundbeck — has failed to show clinical benefit in three randomised trials. Read more

News

A research collaboration for the development of a specific modified peptide targeting rheumatoid arthritis (RA) has been formed between Pfizer and Imcyse — a biotech company developing specific therapies for the treatment of severe chronic diseases. Read more

News

A new government ruling, allowing the erectile dysfunction (ED) drug Sildenafil to be sold without a prescription, could mean drug prices fall further. Read more

News

The US Food and Drug Administration (FDA) has approved Sutent (sunitinib malate) for the adjuvant treatment for adult patients at a high risk of kidney cancer returning after nephrectomy. Read more

News

Two life-extending drugs will now be available to breast cancer patients on the NHS after price negotiations lead the National Institute for Health and Care Excellence (NICE) to approve them. Read more

News

Pfizer has released a statement on its position concerning its consumer healthcare business, revealing that it will be considering a range of strategic alternatives as part of its efforts to best serve patients and maximise value for its shareholders Read more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

Pfizer’s treatment for adults with newly diagnosed acute myeloid leukaemia whose tumors express the CD33 antigen (CD33-positive AML), Mylotarg (gemtuzumab ozogamicin), has been approved by the US Food and Drug Administration (FDA). Read more

News